MG
PDSB icon

Marex Group’s PDS Biotechnology PDSB Stock Holding History

Marex Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,000
Closed -$18.6K – 975
2025
Q2 		$18.6K Hold
14,000
– – ﹤0.01% 627
2025
Q1 		$16.7K Hold
14,000
– – ﹤0.01% 668
2024
Q4 		$22.8K Hold
14,000
– – ﹤0.01% 656
2024
Q3 		$53.5K Hold
14,000
– – ﹤0.01% 562
2024
Q2 		$41K Hold
14,000
– – ﹤0.01% 598
2024
Q1 		$55.4K Hold
14,000
– – ﹤0.01% 446
2023
Q4 		$69.6K Buy
+14,000
New +$69.6K ﹤0.01% 515

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marex Group's PDSB Position: Q3 2025 in Review

Marex Group sold out of PDS Biotechnology (PDSB) in Q3 2025, closing a stake of 14,000 shares — an estimated $18.6K sold.

Marex Group first reported a position in PDSB in Q4 2023 and held it in 7 quarters. The position peaked at $69.6K in Q4 2023. 47 funds tracked by Wall St. Rank hold PDSB as of Q3 2025.

  • Marex Group reported no remaining PDS Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Marex Group sold 14,000 PDS Biotechnology shares in Q3 2025, an estimated $18.6K.
  • Marex Group first reported a position in PDS Biotechnology in Q4 2023 and held it in 7 quarters.
  • Marex Group's PDS Biotechnology position peaked at $69.6K in Q4 2023.
  • 47 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2025.

Based on Marex Group's 13F filing for Q3 2025, filed 14 Nov 2025.